A J Hopfinger

发表

Extraction of pharmacophore information from high-throughput screens.

A J Hopfinger, J S Duca, A. Hopfinger, 2000, Current opinion in biotechnology.

Ames test and antitumor activity of 1-(X-phenyl)-3,3-dialkyltriazenes. Quantitative structure-activity studies based upon molecular shape analysis.

A J Hopfinger, A. Hopfinger, R Potenzone, 1982, Molecular pharmacology.

Conformational analysis of some phenethylamine molecules.

A J Hopfinger, A. Hopfinger, H J Weintraub, 1973, Journal of theoretical biology.

Theoretical study of N-nitrosamines and their presumed proximate carcinogens.

G Klopman, A J Hopfinger, P Andreozzi, 1980, Cancer biochemistry biophysics.

Construction, molecular modeling, and simulation of Mycobacterium tuberculosis cell walls.

A J Hopfinger, A. Hopfinger, Xuan Hong, 2004, Biomacromolecules.

Conformations of complexes between pyrrolo[1,4]benzodiazepines and DNA segments.

A J Hopfinger, A. Hopfinger, M. Mabilia, 1986, Journal of medicinal chemistry.

Prediction of skin irritation from organic chemicals using membrane-interaction QSAR analysis.

A J Hopfinger, A. Hopfinger, M. Robinson, 2001, Toxicological sciences : an official journal of the Society of Toxicology.

Construction of a molecular shape analysis-three-dimensional quantitative structure-analysis relationship for an analog series of pyridobenzodiazepinone inhibitors of muscarinic 2 and 3 receptors.

W J Dunn, A J Hopfinger, B J Burke, 1994, Journal of medicinal chemistry.

A generalized formalism of three-dimensional quantitative structure-property relationship analysis for flexible molecules using tensor representation.

W J Dunn, A J Hopfinger, B J Burke, 1994, Journal of medicinal chemistry.

Quantitative component analysis of mixtures for risk assessment: application to eye irritation.

H. C. Patel, A J Hopfinger, J S Duca, 1999, Chemical research in toxicology.

The rationale for E2020 as a potent acetylcholinesterase inhibitor.

A J Hopfinger, A. Hopfinger, H. Sugimoto, 1996, Bioorganic & medicinal chemistry.

Inhibition of dihydrofolate reductase: structure-activity correlations of 2,4-diamino-5-benzylpyrimidines based upon molecular shape analysis.

A J Hopfinger, A. Hopfinger, 1981, Journal of medicinal chemistry.

Prediction of eye irritation from organic chemicals using membrane-interaction QSAR analysis.

A J Hopfinger, L H Bruner, A. Hopfinger, 2001, Toxicological sciences : an official journal of the Society of Toxicology.

4D-QSAR analysis of a set of propofol analogues: mapping binding sites for an anesthetic phenol on the GABA(A) receptor.

A J Hopfinger, Matthew D Krasowski, A. Hopfinger, 2002, Journal of medicinal chemistry.

A quantitative structure-activity relationship analysis of some 4-aminodiphenyl sulfone antibacterial agents using linear free energy and molecular modeling methods.

R A Pearlstein, A J Hopfinger, A. Hopfinger, 1987, Journal of medicinal chemistry.

Inhibition of dihydrofolate reductase: structure-activity correlations of quinazolines based upon molecular shape analysis.

A J Hopfinger, A. Hopfinger, C Battershell, 1981, Journal of medicinal chemistry.

Solution of the conformation and alignment tensors for the binding of trimethoprim and its analogs to dihydrofolate reductase: 3D-quantitative structure-activity relationship study using molecular shape analysis, 3-way partial least-squares regression, and 3-way factor analysis.

W J Dunn, A J Hopfinger, A. Hopfinger, 1996, Journal of medicinal chemistry.

Characterization of skin penetration processes of organic molecules using molecular similarity and QSAR analysis.

A J Hopfinger, A. Hopfinger, O. Santos-Filho, 2004, Molecular pharmaceutics.

General anesthetic potencies of a series of propofol analogs correlate with potency for potentiation of gamma-aminobutyric acid (GABA) current at the GABA(A) receptor but not with lipid solubility.

N L Harrison, A J Hopfinger, A. Hopfinger, 2001, The Journal of pharmacology and experimental therapeutics.

Prediction and mechanistic interpretation of human oral drug absorption using MI-QSAR analysis.

Jianzhong Liu, A J Hopfinger, A. Hopfinger, 2007, Molecular pharmaceutics.

Theory and application of molecular potential energy fields in molecular shape analysis: a quantitative structure--activity relationship study of 2,4-diamino-5-benzylpyrimidines as dihydrofolate reductase inhibitors.

A J Hopfinger, A. Hopfinger, 1983, Journal of medicinal chemistry.

Three-dimensional molecular shape analysis-quantitative structure-activity relationship of a series of cholecystokinin-A receptor antagonists.

A J Hopfinger, J S Tokarski, 1994, Journal of medicinal chemistry.

Prediction of ligand-receptor binding thermodynamics by free energy force field three-dimensional quantitative structure-activity relationship analysis: applications to a set of glucose analogue inhibitors of glycogen phosphorylase.

P Venkatarangan, A J Hopfinger, 1999, Journal of medicinal chemistry.

QSAR analyses of the substituted indanone and benzylpiperidine rings of a series of indanone-benzylpiperidine inhibitors of acetylcholinesterase.

A J Hopfinger, H Sugimoto, Y Yamanishi, 1992, Journal of medicinal chemistry.

The lattice energetics of some polypeptide chains

A J Hopfinger, A. Hopfinger, 1971, Biopolymers.